Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-23-025913)

Filing Details

Accession Number:: 0001209191-23-025913
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-04-27 19:04:28
Reporting Period:: 2023-04-25

Accepted Time:: 2023-04-27 19:04:28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1679363	Morphic Holding Inc.	MORF	Pharmaceutical Preparations (2834)	473878772

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1779978	P. Praveen Tipirneni	C/O Morphic Holding, Inc. 35 Gatehouse Drive, A2 Waltham MA 02451	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-04-25	25,179	$4.32	39,115	No	4	M	Direct
Common Stock	Disposition	2023-04-25	25,179	$53.40	13,936	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy Common Stock)	Disposition	2023-04-25	25,179	$0.00	25,179	$4.32

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
376,371		2028-12-14	No	4	M	Direct

Footnotes

Includes 395 shares of Common Stock acquired on February 28, 2022, and 862 shares of Common Stock acquired on February 28, 2023 under the Issuer's employee stock purchase plan.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder dated September 16, 2022.
This option is fully vested.